Guardant Health, Inc.

Healthcare · Diagnostics & Research · United States

Last price 178.8 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 23.99B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling test for tumor tissue that provides genomic, transc...